Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

795250

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Huntington's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people have been diagnosed with Huntington's Disease in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	115671
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>‘Finished Admission Episodes’ data show that in the financial year of 2012-13 221 patients received a primary diagnosis of Huntington disease. In the following years 261 (2013-14), 285 (2014-15), 264 (2015-16) and 249 (2016-17) patients, respectively, received a primary diagnosis of Huntington disease.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 14:40:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4131 label Biography information for Jim Shannon

795278

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the timetable is for new genetic technology to be introduced to target prostate cancer treatment on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	115699
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>Prostate cancer is one of the cancers included in the 100,000 Genomes project. Researchers analyse the genetic information through the Genomics England Clinical Interpretation Partnership.</p><p> </p><p>The 100,000 Genomes Project has to date completed 5,356 whole genome sequences of cancer samples, including prostate cancer.</p><p> </p><p>This is leading to the development of new and more personalised diagnostic pathways that will support future research, clinical trials and diagnostic treatment pathways and medicines.</p><p> </p><p>Research results will inform the development of a National Health Service-wide Genomic Medicine Service that maximises the opportunity for research insights to improve outcome of patients, among others, cancer patients including prostate cancer sufferers.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 17:50:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4131 label Biography information for Jim Shannon

795280

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how he plans to ensure that (a) the amount of funding for publicly-funded medical research and development is publicly available and (b) medicine developed from that public research is accessible and affordable.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	115701
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>The Department funds medical research and development through the National Institute of Health Research (NIHR) which provides support for the development of new drugs and treatments, primarily through its investment in early translational research infrastructure in the National Health Service and through a range of research funding programmes.</p><p> </p><p>NIHR awards research funding on a competitive basis. All calls for applications to access NIHR funding are published on publically accessible websites and include funding envelopes available for the call. NIHR also publishes in its annual report details of its annual spend on research broken down into a number of categories.</p><p> </p><p>NIHR supported research generates high quality evidence on the effectiveness and cost-effectiveness of medicines for the NHS and public health services, including informing the National Institute for Health and Care Excellence (NICE) guidance. The results of NIHR supported research are made available publically. For example, the NIHR is the world’s first health research funder to publish comprehensive accounts of its commissioned research within its own publicly and permanently available journal series. Furthermore, the NIHR Dissemination Centre publishes accessible, timely summaries of the most relevant and important research in its 'Signals' series on a weekly basis and other regular reviews of recent, relevant research on key themes.</p><p> </p><p>There is no explicit link between the terms of NIHR research awards and the price the NHS pays for medicines.</p><p> </p><p>NICE assess important new medicines through a robust evaluation process, which ensures they are priced in a manner that is cost-effective for the value they provide to patients and to the NHS. The costs and source of financial support in developing medicines is not a relevant part of this assessment, and there are no plans to include this.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 14:42:42 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4131 label Biography information for Jim Shannon

795281

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with the royal colleges on the use of blood thinners to reduce the occurrence of dementia.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	115702
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>There have been no discussions between the Secretary of State for Health and Royal Colleges on the use of blood thinners to reduce the occurrence of dementia.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 14:46:00 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4131 label Biography information for Jim Shannon

795311

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to recommendation 11 on page 41 in the report by Bliss, Hanging in the Balance, published in 2015, what progress his Department has made towards ensuring that all parents and staff on neonatal units have access to psychological support in line with national standards.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	115732
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>The Five Year Forward View for Mental Health included a specific recommendation for NHS England to improve perinatal services.</p><p> </p><p>The aim is that by 2020/21, there will be increased access to specialist perinatal mental health support in all areas in England, in the community or in-patient mother and baby units, allowing at least an additional 30,000 women each year to receive evidence based treatment, closer to home, when they need it.</p><p> </p><p>The Department and NHS England have committed a total investment from 2015/16 to 2020/21 of £365 million to support this expanded service.</p><p> </p><p>For National Health Service staff, NHS England launched a £5 million programme of health and wellbeing support in 2015, which included measures to help staff deal with stress and mental ill health.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 14:39:06 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft

795326

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health what (a) powers and (b) responsibilities have been conferred on the Care Quality Commission to regulate fees charged by private nursing homes.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	115747
answer	answer is ministerial correction date of answer 04/12/2017 answer text <p>As the independent regulator of health and adult social care providers in England, the Care Quality Commission (CQC) is responsible for deciding its own regulatory inspection and assessment framework.</p><p> </p><p>The CQC has no power to regulate fees charged by private nursing homes – or any other registered provider.</p><p> </p><p>However, the CQC (Registration) Regulations 2009: Regulation 19 places an obligation on registered providers to provide timely and accurate information about the cost of their care and treatment to people who use services. To meet this regulation, providers must make written information available about any fees, contracts and terms and conditions, where people are paying either in full or in part for the cost of their care, treatment and support. This can be assessed as part of a CQC inspection, and the CQC has the power to prosecute providers for a breach of the whole or part of this regulation. The CQC will refuse registration if providers cannot provide satisfactory assurance that they can and will continue to comply with this regulation.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 04/12/2017 11:15:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1538 label Biography information for Rosie Cooper

795327

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health whether private nursing homes are required to disclose nursing care costs in the contracts of people receiving care packages.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	115748
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>The Department is unable to comment on the specific contracts between individuals and care providers, or on individual cases.</p><p> </p><p>On 30 November 2017, the Competition and Markets Authority published a market study into care homes, which included findings and recommendations about the transparency of costs and contracts. The full study is available at the following link:</p><p><a href="https://www.gov.uk/cma-cases/care-homes-market-study" target="_blank">https://www.gov.uk/cma-cases/care-homes-market-study</a></p><p>The Government take seriously the findings and the recommendations of this report, all of which will need to be carefully considered. The Government is committed to publish a formal response to the Competition and Markets Authority report within 90 days. We will also need to take forward these complex issues raised by the Competition and Markets Authority as part of the Green Paper on adult social care which will be published in summer 2018.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 13:46:51 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1538 label Biography information for Rosie Cooper

795351

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the report by Health Education England, Stepping forward to 2020-21: The mental health workforce plan for England’, published in July 2017, how many and what proportion of the new mental health workforce recruits will be trained as occupational therapists.
tabling member constituency	Stockton South
tabling member printed	Dr Paul Williams
uin	115772
answer	answer is ministerial correction date of answer 30/11/2017 answer text <p>The breakdown of the overall increase in workforce that the ‘Stepping forward to 2020/21: The mental health workforce plan for England’ will deliver will be defined by local needs.</p><p> </p><p>Health Education England is working with a number of partners, including National Health Service trusts, to assess demand and supply for clinical staff, including occupational therapists.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 115609 question first answered 30/11/2017 14:15:06 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4666 label Biography information for Dr Paul Williams

795359

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Four Seasons Health Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what contingency plans his Department has for the possibility of a collapse of the Four Seasons care home operator.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	115780
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>The Care Quality Commission (CQC) continues to monitor the situation with Four Seasons Healthcare Group through the Market Oversight scheme. Market Oversight is a statutory scheme, as set out in the Care Act 2014, through which the CQC assesses the financial sustainability of those care organisation that local authorities may find difficult to replace should they fail and become unable to carry on delivering services.</p><p> </p><p>The Care Act 2014 places temporary duties on local authorities to intervene to protect individuals where a care provider is no longer able to carry on because of business failure and services cease.</p><p> </p><p>In 2015, Local Government Implementation Unit, Local Government Association, Association Directors of Adult Social Services and the Department published guidance to local authorities on contingency planning for provider failure. The Government is continuing to work with local authorities to ensure they have effective and up-to-date contingency plans in place.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 14:45:08 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	318 label Biography information for John Spellar

795431

registered interest
date	27/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress has been made on aiding medical research using NHS data gathering.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	115852
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>The Government is committed to ensuring the health and care system in England realises the full benefits of sharing data in a safe, secure and legal way and is developing a simple, accessible way for patients to opt out of sharing their data for reasons other than their individual care and treatment.</p><p> </p><p>Recognising that sharing information and data offers immense potential to improve the National Health Service and social care system, unlock new treatments and medical breakthroughs, and improve our and others lives, we are keen to ensure these benefits are understood by the public.</p><p> </p><p>It is crucial, if data and information is to be used effectively to support better health and care outcomes that the public has trust and confidence that there are strong safeguards in place to protect their data from inappropriate use.</p><p> </p><p>The Government has committed to put the role of the National Data Guardian on a statutory footing. This function will work to ensure that citizens’ confidential information is safeguarded securely whilst being used legally and transparently.</p><p> </p><p>The Government is also committed to supporting innovation and improvement through the safe and secure use of data from the health and care system. NHS Digital is the trusted national provider of high-quality information, data and IT systems for health and social care, with a statutory duty in the Health and Social Care Act 2012, to assure the quality of all the data it collects, publishes and makes available, under strict controls, to the research community.</p><p> </p><p>At present a wide range of data are collected from the NHS to support a range of secondary uses including within the research community. Recognising the value and importance of this data, NHS Digital has made a number of commitments to the Life Sciences Industrial Strategy. These include leading, alongside NHS England and Health Data Research UK, the development of Local Care Record exemplars and regional Digital Innovation hubs. The hubs will create controlled environments for real-world clinical studies and the comprehensive evaluation of new innovations so that patients can benefit from scientific breakthroughs much faster.</p><p> </p><p>In addition, NHS Digital has set out national standards and approaches for data and interoperability and sponsors the Professional Records Standards Body to define the standards needed for good care records which are the foundation of strong data for research.</p><p> </p><p>To support researchers understanding of the data access environment, NHS Digital is also rolling out a series of Roadshows for Researchers which will take place throughout the winter.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/12/2017 17:51:55 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3939 label Biography information for Andrew Percy